Avoiding Redundant Macrolide Combinations

Introduction to Macrolide Therapy

The American Academy of Family Physicians, Annals of Internal Medicine, and MMWR Recommendations and Reports recommend against combining clarithromycin and azithromycin for treating bacterial infections due to lack of additive benefit and overlapping mechanisms of action 1, 2, 3

The combination of clarithromycin with azithromycin has never been studied or recommended for MAC prophylaxis, despite extensive research on various combination regimens, as stated by the American Academy of Family Physicians, Annals of Internal Medicine, and MMWR Recommendations and Reports 1, 2, 3
When clarithromycin was combined with rifabutin, it was no more effective than clarithromycin alone and caused more adverse effects, according to the American Academy of Family Physicians and Annals of Internal Medicine 1, 2, 3
When azithromycin was combined with rifabutin, it was more effective than azithromycin alone, but the combination still wasn't routinely recommended due to increased adverse effects, drug interactions, and no survival benefit, as reported by the American Academy of Family Physicians, Annals of Internal Medicine, and MMWR Recommendations and Reports 1, 2, 3

Using both macrolides simultaneously would increase pill burden, cost, and potential for adverse effects without providing additional therapeutic benefit, as stated by Annals of Internal Medicine and MMWR Recommendations and Reports 2, 4
The combination increases risk of QT interval prolongation, as both azithromycin and clarithromycin can prolong the QT interval independently, according to non-Praxis Medical Insights sources, such as the European Society of Cardiology 5, 6

For MAC prophylaxis in HIV patients, either clarithromycin or azithromycin as monotherapy is the preferred approach, and never combine the two macrolides together, as recommended by the American Academy of Family Physicians, Annals of Internal Medicine, and MMWR Recommendations and Reports 1, 2, 3